ACE/Angiotension receptors

Citations 161-170 of 225 total displayed.

Past content (since Jun 1999):

Current Perspectives
New Approaches to Antiarrhythmic Therapy, Part II: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias: Members of the Sicilian Gambit
Circulation 2001;104:2990-2994, doi:10.1161/hc4901.099493 [Abstract] [Full text]

Current Perspectives
New Approaches to Antiarrhythmic Therapy, Part I: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias: Members of the Sicilian Gambit
Circulation 2001;104:2865-2873, doi:10.1161/hc4801.099491 [Abstract] [Full text]

Basic Science Reports
Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury: Lan Wu, Masaru Iwai, Hironori Nakagami, Zhen Li, Rui Chen, Jun Suzuki, Masahiro Akishita, Marc de Gasparo, and Masatsugu Horiuchi
Circulation 2001;104:2716-2721, doi:10.1161/hc4601.099404 [Abstract] [Full text]

Basic Science Reports
Vascular Hypertrophy and Increased P70S6 Kinase in Mice Lacking the Angiotensin II AT₂ Receptor: Marc Brede, Kerstin Hadamek, Lorenz Meinel, Frank Wiesmann, Jörg Peters, Stefan Engelhardt, Andreas Simm, Axel Haase, Martin J. Lohse, and Lutz Hein
Circulation 2001;104:2602-2607, doi:10.1161/hc4601.099401 [Abstract] [Full text]

Correspondence
Endothelin Receptor Blockade in Congestive Heart Failure: Tsung O. Cheng
Circulation 2001;104:e96 [Full text]

Clinical Investigations and Reports
Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure: Fraser N. Witherow, Ahmed Helmy, David J. Webb, Keith A.A. Fox, and David E. Newby
Circulation 2001;104:2177-2181, doi:10.1161/hc4301.098252 [Abstract] [Full text]

AHA Scientific Statements Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy: A Statement for Healthcare Professionals From the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association: Anton C. Schoolwerth, Domenic A. Sica, Barbara J. Ballermann, and Christopher S. Wilcox
Circulation 2001;104:1985-1991, doi:10.1161/hc4101.096153 [Full text]

Correspondence
Angiotensin II Type 1 Receptor Blockers and Congestive Heart Failure • Response: Johann W. Auer, Robert Berent, Bernd Eber, and Michel Burnier
Circulation 2001;104:e82 [Full text]

Clinical Investigations and Reports Vasoconstrictor Effect of the Angiotensin-Converting Enzyme–Resistant, Chymase-Specific Substrate [Pro¹¹_D-Ala¹²] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans: John E. McDonald, Neal Padmanabhan, Mark C. Petrie, Chris Hillier, John M.C. Connell, and John J.V. McMurray
Circulation 2001;104:1805-1808, doi:10.1161/hc4001.097220 [Abstract] [Full text]

Current Perspectives
Are ACE Inhibitors a "Magic Bullet" Against Oxidative Stress?: Thomas Münzel and John F. Keaney, Jr
Circulation 2001;104:1571-1574, doi:10.1161/hc3801.095585 [Full text]

Subspecialty Collections Home

Show ACE/Angiotension receptors
collections from other journals.